Jennifer Leveque
Jennifer Leveque received her bachelor’s degree in integrated neuroscience from Binghamton University in 2011. She has eight years of experience in clinical research and in the pharmaceutical industry. While obtaining a master’s degree in interdisciplinary health sciences at Drexel University College of Medicine, she was trained in clinical research with the retina service at the University of Pennsylvania’s Scheie Eye Institute. Her contributions to Frontotemporal Lobar Degeneration (FTLD) and the use of optical coherence tomography (OCT) to distinguish subtypes of FTLD was published in Neurology.
Leveque most recently worked for IQVIA, a biotech and clinical research organization (CRO), providing services for sponsor company, Genentech/Roche. Her strong organization and interpersonal skills quickly propelled her into various clinical research leadership roles. Her unique blend of in-house and in-the-field experience has led to success in managing clinical studies and bringing forth positive and timely trial results.
Detail-oriented, Leveque performs well on audit clean-up teams and on FDA submissions teams. She helps to achieve each of her clinical research teams’ goals and is passionate and enthusiastic about drug development and research in therapeutic areas of oncology and ophthalmology.
